Article
The current treatment of Hepatitis C.
Minerva gastroenterologica e dietologica - 1 Jun 2016
Arleo Andrea, Mangia Alessandra
Abstract excerpt
The development of potent antivirals able to directly block multiple step of viral lifecycle (DAAs) led to a revolution in HCV treatment. These compounds are associated with unprecedent high rates of SVR and can be administered orally, regardless of the severity of the associated liver disease, allowing treatment of large number of HCV infected patients. Three main classes of DAAs are currently available, NS3/4...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.